Institutional Ownership Santen Pharmaceutical CO Unspo (SNPHY)
This table provides information about the institutional ownership of Santen Pharmaceutical CO Unspo (SNPHY). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 362 shares, which have been reported (via 13F filing form) to have a value of $3,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Copeland Capital Management, LLC
|
Jan 24, 2025 Q4 2024 |
230
shares
|
$2,272
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Private Capital Group, LLC
|
Jul 28, 2022 Q2 2022 |
76
shares
|
$750
0.0% of portfolio
|
Q2 2022
Added 111.11%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
30
shares
|
$296
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
Nov 08, 2024 Q3 2024 |
26
shares
|
$256
0.0% of portfolio
|
Q1 2024
New holding
|